PMID- 19625374 OWN - NLM STAT- MEDLINE DCOM- 20091027 LR - 20211020 IS - 1522-1466 (Electronic) IS - 1931-857X (Print) IS - 1522-1466 (Linking) VI - 297 IP - 4 DP - 2009 Oct TI - Lipopolysaccharide directly alters renal tubule transport through distinct TLR4-dependent pathways in basolateral and apical membranes. PG - F866-74 LID - 10.1152/ajprenal.00335.2009 [doi] AB - Bacterial infection of the kidney is associated with renal tubule dysfunction and dysregulation of systemic electrolyte balance. Whether bacterial molecules directly affect renal tubule transport is unknown. We examined the effects of LPS on HCO3(-) absorption in the isolated rat and mouse medullary thick ascending limb (MTAL). LPS decreased HCO3(-) absorption when added to bath or lumen. The MEK/ERK inhibitor U0126 eliminated inhibition by bath LPS but had no effect on inhibition by lumen LPS. Conversely, the mammalian target of rapamycin (mTOR) inhibitor rapamycin eliminated inhibition by lumen LPS but had no effect on inhibition by bath LPS. Inhibiting basolateral Na(+)/H(+) exchange with amiloride eliminated inhibition of HCO3(-) absorption by lumen but not bath LPS. Confocal immunofluorescence showed expression of TLR4 in basolateral and apical membrane domains. Inhibition of HCO3(-) absorption by bath and lumen LPS was eliminated in MTALs from TLR4(-/-) mice. Thus LPS inhibits HCO3(-) absorption through distinct TLR4-dependent pathways in basolateral and apical membranes. These results establish that bacterial molecules can directly impair the transport function of renal tubules, identifying a new mechanism contributing to tubule dysfunction during bacterial infection. The LPS-induced reduction in luminal acidification may contribute to Gram-negative pathogenicity by promoting bacterial adherence and growth and impairing correction of infection-induced systemic acid-base disorders. FAU - Good, David W AU - Good DW AD - Div. of Nephrology, 4.200 John Sealy Annex, The Univ. of Texas Medical Branch, 301 Univ. Blvd., Galveston, TX 77555-0562, USA. dgood@utmb.edu FAU - George, Thampi AU - George T FAU - Watts, Bruns A 3rd AU - Watts BA 3rd LA - eng GR - R01 DK038217/DK/NIDDK NIH HHS/United States GR - R01 DK-038217/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20090722 PL - United States TA - Am J Physiol Renal Physiol JT - American journal of physiology. Renal physiology JID - 100901990 RN - 0 (Bicarbonates) RN - 0 (Butadienes) RN - 0 (Lipid A) RN - 0 (Lipopolysaccharides) RN - 0 (Nitriles) RN - 0 (Tlr4 protein, mouse) RN - 0 (Tlr4 protein, rat) RN - 0 (Toll-Like Receptor 4) RN - 0 (U 0126) RN - 7DZO8EB0Z3 (Amiloride) RN - W36ZG6FT64 (Sirolimus) SB - IM CIN - Am J Physiol Renal Physiol. 2009 Oct;297(4):F864-5. PMID: 19675179 MH - Amiloride MH - Animals MH - Bicarbonates/*metabolism MH - Butadienes MH - Disease Progression MH - Endotoxemia/metabolism/microbiology MH - Escherichia coli Infections/immunology/*metabolism/physiopathology MH - Escherichia coli K12 MH - Immunity, Innate MH - In Vitro Techniques MH - Kidney Tubules/*metabolism/physiopathology MH - Lipid A MH - Lipopolysaccharides MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Nitriles MH - Rats MH - Rats, Sprague-Dawley MH - Serum MH - Signal Transduction MH - Sirolimus MH - Toll-Like Receptor 4/*metabolism MH - Urinary Tract Infections/*metabolism/microbiology/physiopathology PMC - PMC2775577 EDAT- 2009/07/25 09:00 MHDA- 2009/10/29 06:00 PMCR- 2010/10/01 CRDT- 2009/07/24 09:00 PHST- 2009/07/24 09:00 [entrez] PHST- 2009/07/25 09:00 [pubmed] PHST- 2009/10/29 06:00 [medline] PHST- 2010/10/01 00:00 [pmc-release] AID - 00335.2009 [pii] AID - F-00335-2009 [pii] AID - 10.1152/ajprenal.00335.2009 [doi] PST - ppublish SO - Am J Physiol Renal Physiol. 2009 Oct;297(4):F866-74. doi: 10.1152/ajprenal.00335.2009. Epub 2009 Jul 22.